Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration

Basal Ganglia Hematoma Clinical Trial

Official title: Intracavitary Injection of Human Umbilical Cord Mesenchymal Stem Cells in Acute Basal Ganglia Hematoma After Stereotactic Aspiration: a Randomized, Single-blind, Placebo-Controlled, Phase 2 Trial

Status Recruiting

Clinical Trial Summary

A study to examine the safety and potential effectiveness of human umbilical cord mesenchymal stem cells (hUMSCs) in adults who have suffered spontaneous cerebral hemorrhage in basal ganglia. The hypothesis is that hUMSCs will be safe and can improve neurological function after intracerebral hemorrhage so that improve the prognosis of patients.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Basal Ganglia Hematoma
• Basal Ganglia Hemorrhage
• Ganglion Cysts
• Hematoma

• NCT number: NCT04074408
• Study type: Interventional
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: Jianmin Zhang, Doctor
• Phone: 86-13805722695
• Email: 2307010@zju.edu.cn
• Status: Recruiting
• Phase: Phase 2
• Start date: May 2020
• Completion date: November 2023